Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

The Cancer Breakthroughs session of ASTRO2022 included research findings presented on behalf of the American Society of Clinical Oncology (ASCO) and the American Association of Physicists in Medicine (AAPM). Photo credit: ASTRO
Feature | ASTRO | Christine Book
ASTRO 2022 Shines Spotlight on “Cancer Breakthroughs” with AAPM, ASCO Research

The Imaging Technology News (ITN) editorial team is pleased to present the second portion of the American Society for ...

Time January 13, 2023
arrow
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James)
News | Proton Therapy
Leading U.S. Cancer Center Selects RayStation for Proton Planning

January 13, 2023 — RaySearch Laboratories AB announces that The Ohio State University Comprehensive Cancer Center - ...

Time January 13, 2023
arrow
RaySearch Laboratories AB announced that CGN Medical Technologies has in December 2002 placed an order for RayStation, which CGN has sold together with IBA’s proton therapy system to Yangzhou Hospital in China.
News | Proton Therapy
CGN Selects RayStation for Yangzhou Hospital

January 9, 2023 — RaySearch Laboratories AB announced that CGN Medical Technologies has in December 2002 placed an order ...

Time January 08, 2023
arrow
Top 20 for 2022
Feature | Radiology Business | By Melinda Taschetta-Millane
ITN's Top 20 from 2022

As 2022 comes to a close, the Imaging Technology News team takes a look at the year's most viewed content. Here is a ...

Time January 02, 2023
arrow
Patients for Safer Nuclear Medicine calls NRC ruling a victory, notes work to protect patients is not over
News | Nuclear Imaging
Patient Coalition Applauds Federal Decision Impacting Nuclear Medicine Safety

January 2, 2023 — The federal agency that oversees the administration of nuclear medicine has announced that it will ...

Time January 02, 2023
arrow
 IBA, a world leader in particle accelerator technology, today confirms that it has signed a contract with the Spanish Ministry of Health to install ten proton therapy systems across Spain as part of a significant public tender.
News | Proton Therapy
IBA Wins 10 Proton Therapy System Contract in Spain

January 2, 2023 — IBA, a world leader in particle accelerator technology, today confirms that it has signed a contract ...

Time January 02, 2023
arrow
The ITN team wishes you a happy and healthy New Year!
News | Imaging Technology News - ITN
Happy New Year from ITN

The ITN team wishes you a happy and healthy New Year!

Time January 01, 2023
arrow
New technology expected to drive efficiency with condensed treatment courses, fewer side effects, and improved outcomes for people with cancer
News | Linear Accelerators
First Ever Patient Treated for Pancreatic Cancer Using Elekta Unity MR-Linac

December 30, 2022 — A milestone was reached in radiation therapy last week as the first patients completed their full ...

Time December 30, 2022
arrow
December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including leukemias, lymphomas and breast cancer. Anthracyclines — such as doxorubicin, frequently used against breast cancer — kill cancer cells by damaging their DNA. However, these effective chemotherapies also cause toxic effects in the heart in about ten percent of patients that can eventually lead to heart failure, particularly in older patients with pre-existing cardiovascular disease. Current
News | Breast Imaging
Researchers ID Protein that may Protect the Heart During Certain Cancer Treatment Regimens

December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including ...

Time December 29, 2022
arrow
Artificial intelligence is used at the University of Pittsburgh Medical Center to support pathologists diagnosing prostate cancer
News | Digital Pathology
Ibex Deploys AI-powered Cancer Diagnostics Solution at UPMC

December 22, 2022 — Ibex Medical Analytics (Ibex), a leader in AI-powered cancer diagnostics, today announced the live ...

Time December 22, 2022
arrow
Abhinav Jha to develop technique, test in patients with metastatic prostate cancer
News | Radiation Therapy
Imaging Technique May Measure Absorbed Dose from Radiation Therapy

December 22, 2022 — Patients with cancer that has spread to the bone are sometimes treated with alpha particle radiation ...

Time December 22, 2022
arrow
An imaging agent just approved by the FDA will allow surgeons to identify additional cancerous lesions, which otherwise would have been left behind, in up to 24% more patients during non-small cell lung cancer surgery. Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, is an inventor of the foundational intellectual property upon which the drug is based.
News | Lung Imaging
Imaging Agent Illuminates Lung Cancer Tumors

December 21, 2022 — Surgery, especially surgery to remove cancerous tumors, relies on a range of tools and techniques as ...

Time December 21, 2022
arrow
ASTRO's statement stresses that it is deeply disappointed in radiation oncology cuts and fears for stability of community-based cancer clinics
News | ASTRO
ASTRO Issues Statement in Response to 2023 Omnibus Appropriations Bill

December 20, 2022 — The American Society for Radiation Oncology (ASTRO) issued the following statement from ASTRO Board ...

Time December 20, 2022
arrow
Update to 2014 guidance outlines best practices for patient-centered, multidisciplinary care
News | Radiation Therapy
ASTRO Issues Updated Guideline on Radiation Therapy for Endometrial Cancer

December 8, 2022 — A newly updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...

Time December 08, 2022
arrow
News | RSNA
Study compares effect of food intake on manganese-based MRI contrast agent absorption

December 3, 2022 — Results from its Orviglance Food Effect study were presented by Ascelia Pharma, a biopharmaceutical ...

Time December 03, 2022
arrow
18F-rhPSMA-7.3 PET image showing multiple areas of uptake in the prostate gland in a man with newly diagnosed prostate cancer Photo courtesy of Blue Earth Diagnostics
News | Prostate Cancer
Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer

December 2, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time December 02, 2022
arrow
Dunlee unveiled its new oncology bundles in the U.S. for the first time at Radiological Society of North America’s 2022 annual conference.
News | Radiation Oncology
Dunlee Unveils New Oncology Bundles at RSNA22

November 28, 2022 — Dunlee unveiled its new oncology bundles in the U.S. for the first time at Radiological Society of ...

Time November 28, 2022
arrow
The Imaging Technology News (ITN) editorial team reported on highlights from day one of the RSNA 108th Scientific Assembly and Annual Meeting being held at McCormick Place in Chicago, IL.
News | RSNA | By Christine Book
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging

November 27, 2022 — Among dozens of technical exhibit visits, informative discussions, and captivating Plenary Session ...

Time November 27, 2022
arrow
Researchers at the University of Wisconsin–Madison will kick off research scanning human subjects with GE Healthcare’s latest generation PCCT prototype in December 2022, representing the first U.S. clinical evaluation site with GE Healthcare’s pure silicon CT detector technology
News | Proton Therapy
UW–Madison To Perform the First U.S. Evaluation of GE Healthcare’s Photon Counting CT Technology with Deep Silicon Detectors

November 25, 2022 — Researchers at the University of Wisconsin–Madison, the first U.S. clinical evaluation site for GE ...

Time November 25, 2022
arrow
Videos | ASTRO
VIDEO: Randomized Phase III Trial of Hypo Fractionated Whole Breast Irradiation with Concurrent Boost vs. Conventional Whole Breast Irradiation

Dr. Frank A. Vicini, MD, FACR, FASTRO, FABS, who is a radiation oncologist with GenesisCare, discussed his findings from ...

Time November 09, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now